Get it on Google Play

Lilly's Jaypirca gets EU approval recommendation for CLL

June 26, 2026 7:17 AM EDT Send to a Friend
Eli Lilly and Company (NYSE: LLY) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login